C-EVWBMethuselah Health
proteomics, LC-MS/MS, bioinformatics
discoverydiscovering
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-EVWB
C-EVWBC-EVWBproteomics, LC-MS/MS, bioinformatics
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Methuselah Health proteomics, LC-MS/MS, bioinformatics
Methuselah Health developed ProQuant, a proprietary LC-MS/MS bottom-up proteomics platform. The page states that RxCelerate acquired Methuselah Health in 2022 and now offers ProQuant to support drug development projects. ProQuant is described as quantifying proteins, modifications, variants, and cleavages to provide deeper biological insight.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Methuselah Health — Far from goals · Lower middle. Derived deterministically from 2 extracted project(s). Most-advanced status: undisclosed. Band: far. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic